INTERNATIONAL PATENT: ARENA PHARMACEUTICALS, INC. FILES APPLICATION FOR "BEXICASERIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF EPILEPTIC DISORDERS IN A CHILD PATIENT"

GENEVA, Feb. 4 -- ARENA PHARMACEUTICALS, INC. (66 Hudson Boulevard EastNew York, New York 10007-2192) filed a patent application (PCT/US2025/039335) for "BEXICASERIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF EPILEPTIC DISORDERS IN A CHILD PATIENT" on Jul 25, 2025. With publication no. WO/2026/025075, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OREVILLO, Chadwick J. (c/o Longboard Pharmaceuticals, Inc.4275 Executive Square, Suite 950La Jolla, California 92037), KAYE, Randall (c/o Longboard Pharmaceuticals, Inc.4275...